Infection at the injection site is a rare but serious risk anytime needles are introduced
If this continues, it is recommended to stop
However, our professional stance remains that any food will compromise optimal absorption to some degree.
Patients already using exogenous growth hormone, IGF-1, or GHS-R agonists (such as ipamorelin or tesamorelin) may be stacking mechanisms that amplify both therapeutic effects and risk profiles, including insulin resistance and tissue proliferation
One-meal-per-day eaters are actually ideal candidates for cagrilintide timing optimization because there's no ambiguity about which meal to target
The choice between SLU-PP-332 and 5-amino-1mq will depend on the specific therapeutic goals, patient characteristics, and the evolving landscape of clinical evidence